価格表

在庫・価格 : 2024年04月26日 04時03分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IFN-γ, Mouse, ELISpot Kit
データシート※最新のデータシートでない場合があります
EL485 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥80,000
(未発注)
追加

在庫・価格 : 2024年04月26日 04時03分 現在

IFN-γ, Mouse, ELISpot Kit

  • 商品コード:EL485
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥80,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Chen BJ et al. Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. Blood 2002 May;99(9):3083-8
Chen BJ et al
2002/01/01
Sample Type: Whole Cells PubMed
2 Baron JL et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002 Apr;16(4):583-94
Baron JL et al
2002/01/01
Sample Type: Whole Cells PubMed
3 Dredge K et al. Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity. J. Immunol. 2002 May;168(10):4914-9
Dredge K et al
2002/01/01
Sample Type: Whole Cells PubMed
4 Maecker B et al. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood 2003 Nov;102(9):3287-94
Maecker B et al
2003/01/01
Sample Type: Whole Cells PubMed
5 Wan T et al. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 2004 Mar;103(5):1747-54
Wan T et al
2004/01/01
Sample Type: Whole Cells PubMed
6 Huang YH et al. Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens. J. Virol. 2003 Dec;77(24):12980-5
Huang YH et al
2003/01/01
Sample Type: Whole Cells PubMed
7 Wang D et al. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs. Int. J. Oncol. 2004 Apr;24(4):901-8
Wang D et al
2004/01/01
Species: Mouse, Sample type: Whole Cells PubMed
8 Li AF et al. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine 2004 Apr;22(13-14):1751-63
Li AF et al
2004/01/01
Sample Type: Whole Cells PubMed
9 Kwak H et al. Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion. Virology 2004 May;322(2):337-48
Kwak H et al
2004/01/01
Sample Type: Whole Cells PubMed
10 Luby TM et al. Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1. Clin. Immunol. 2004 Jul;112(1):45-
Luby TM et al
2004/01/01
Sample Type: Whole Cells PubMed
11 Sakai Y et al. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice. Cancer Res. 2004 Nov;64(21):8022-8
Sakai Y et al
2004/01/01
Sample Type: Whole Cells PubMed
12 Lou Y et al. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res. 2005 Sep;65(17):7926-33
Lou Y et al
2005/01/01
Sample Type: Whole Cells PubMed
13 Aulwurm S et al. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo. Int. J. Cancer 2006 Apr;118(7):1728-35
Aulwurm S et al
2006/01/01
Sample Type: Whole Cells PubMed
14 Berm炭dez-Humar叩n LG et al. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol. 2005 Dec;175(11):7
Berm炭dez-Humar叩n LG et al
2005/01/01
Sample Type: Whole Cells PubMed
15 Savino C et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J. Neuroimmunol. 2006 Mar;172(1-2):27-37
Savino C et al
2006/01/01
Sample Type: Whole Cells PubMed
16 Malowany JI et al. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol. Ther. 2006 Apr;13(4):766-75
Malowany JI et al
2006/01/01
Sample Type: Whole Cells PubMed
17 Ma XT et al. Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses. Cancer Res. 2006 Jan;66(2):1169-76
Ma XT et al
2006/01/01
Sample Type: Whole Cells PubMed
18 Young KR et al. Elicitation of immunity to HIV type 1 Gag is determined by Gag structure. AIDS Res. Hum. Retroviruses 2006 Jan;22(1):99-108
Young KR et al
2006/01/01
Application: ELISpot Development, Sample Type: Whole Cells PubMed
19 Kumar S et al. Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India. Vaccine 2006 Mar;24(14):2585-93
Kumar S et al
2006/01/01
Sample Type: Whole Cells PubMed
20 Ohmura-Hoshino M et al. Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 2006 Jul;177(1):341-54
Ohmura-Hoshino M et al
2006/01/01
Species: Mouse, Sample type: Whole Cells PubMed
21 Blazevic V et al. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. AIDS Res. Hum. Retroviruses 2006 Jul;22(7):667-77
Blazevic V et al
2006/01/01
Sample Type: Whole Cells PubMed
22 Zhao X et al. Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag. J. Virol. 2006 Sep;80(18):8880-90
Zhao X et al
2006/01/01
Sample Type: Whole Cells PubMed
23 Viner KM et al. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals. Virology 2007 May;361(2):356-63
Viner KM et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
24 Kurooka M et al. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res. 2007 Jan;67(1):227-36
Kurooka M et al
2007/01/01
Sample Type: Whole Cells PubMed
25 Lou Y et al. Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1. Vaccine 2007 Mar;25(12):2331-9
Lou Y et al
2007/01/01
Sample Type: Whole Cells PubMed
26 Malm M et al. GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model. Vaccine 2007 Apr;25(17):3293-301
Malm M et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
27 Song S et al. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice. Vaccine 2007 Jun;25(25):4853-60
Song S et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
28 Xu B et al. Synergistic antileukemia effect of combinational gene therapy using murine beta-defensin 2 and IL-18 in L1210 murine leukemia model. Gene Ther. 2007 Aug;14(15):1181-7
Xu B et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
29 Manning EA et al. A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism. Clin. Cancer Res. 2007 Jul;13(13):3951-9
Manning EA et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
30 Gill N et al. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15. Eur. J. Immunol. 2007 Sep;37(9):2529-38
Gill N et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
31 Cortes-Perez NG et al. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 2007 Sep;25(36):6581-8
Cortes-Perez NG et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
32 Yamaguchi S et al. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines. Cancer 2007 Oct;110(7):1469-77
Yamaguchi S et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
33 Barcia C et al. One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications. Mol. Ther. 2007 Dec;15(12):2154-63
Barcia C et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
34 Koncz A et al. Nitric oxide mediates T cell cytokine production and signal transduction in histidine decarboxylase knockout mice. J. Immunol. 2007 Nov;179(10):6613-9
Koncz A et al
2007/01/01
Species: Mouse, Sample type: Whole Cells PubMed
35 Yang J et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation 2008 Feb;117(5):660-9
Yang J et al
2008/01/01
Species: Mouse, Sample type: Whole Cells PubMed
36 Lopez R et al. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J. Immunol. 2008 Oct;181(7):4908-17
Lopez R et al
2008/01/01
Species: Mouse, Application: Whole Cells PubMed
37 Dagenais TR et al. T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions. Infect. Immun. 2009 Jan;77(1):141-51
Dagenais TR et al
2009/01/01
Sample Type: Whole Cells PubMed
38 Divangahi M et al. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 2008 Nov;181(10):7157-65
Divangahi M et al
2008/01/01
Sample Type: Whole Cells PubMed
39 Zhu Q et al. Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection. Mucosal Immunol 2008 Jan;1(1):78-88
Zhu Q et al
2008/01/01
Sample Type: Whole Cells PubMed
40 Robinson M et al. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J. Virol. 2009 Apr;83(8):3450-62
Robinson M et al
2009/01/01
Sample Type: Whole Cells PubMed
41 McBurney SP et al. Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine 2009 Jul;27(32):4337-49
McBurney SP et al
2009/01/01
Sample Type: Whole Cells PubMed
42 Kopecky-Bromberg SA et al. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 2009 Jun;27(28):3766-74
Kopecky-Bromberg SA et al
2009/01/01
Sample Type: Whole Cells PubMed
43 M旦lder T et al. Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV--study in domestic pigs. Vaccine 2009 Dec;28(2):293-8
M旦lder T et al
2009/01/01
Sample Type: Whole Cells PubMed
44 De Koker S et al. Biodegradable polyelectrolyte microcapsules: antigen delivery tools with Th17 skewing activity after pulmonary delivery. J. Immunol. 2010 Jan;184(1):203-11
De Koker S et al
2010/01/01
Sample Type: Whole Cells PubMed
45 Masalova OV et al. The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization. Vaccine 2010 Feb;28(8):1987-96
Masalova OV et al
2010/01/01
Sample Type: Whole Cells PubMed
46 Ponte JF et al. Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody. Immunology 2010 Jun;130(2):231-42
Ponte JF et al
2010/01/01
Sample Type: Whole Cells PubMed
47 Kundu S et al. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J. Immunol. 2010 Jun;184(11):6529-36
Kundu S et al
2010/01/01
Sample Type: Whole Cells PubMed
48 Wu CY et al. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS ONE 2012;7(8):e42363
Wu CY et al
2012/01/01
Sample Type: Whole Cells PubMed
49 Savino MT et al. The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. J. Leukoc. Biol. 2013 Apr;93(4):549-59
Savino MT et al
2013/01/01
Sample Type: cell supernates PubMed
50 Walsh MP et al. Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. PLoS ONE 2013;8(3):e58860
Walsh MP et al
2013/01/01
Sample Type: tissue homogenate PubMed
51 Gupta S et al. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. J. Virol. 2014 Feb;88(3):1492-501
Gupta S et al
2014/01/01
Sample Type: Whole Cells PubMed
52 Lv L et al. Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus. J. Vet. Sci. 2014;15(2):209-16
Lv L et al
2014/01/01
Sample Type: cell supernates PubMed
53 Kanagavelu S et al. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS ONE 2014;9(2):e90100
Kanagavelu S et al
2014/01/01
Sample Type: Whole Cells PubMed
54 Kumari S et al. Epidermal RelA specifically restricts contact allergen-induced inflammation and apoptosis in skin. J. Invest. Dermatol. 2014 Oct;134(10):2541-50
Kumari S et al
2014/01/01
Sample Type: Whole Cells PubMed
55 Reynolds C et al. Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile. BMC Biol. 2014;12:32
Reynolds C et al
2014/01/01
Sample Type: Cell culture media PubMed
56 King TH et al. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS ONE 2014;9(7):e101904
King TH et al
2014/01/01
Sample Type: cell suspensions PubMed
57 Gil-Farina I et al. Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis. J. Immunol. 2016 Sep;197(6):2145-56
Gil-Farina I et al
2016/01/01
Sample Type: Whole Cells PubMed
58 Lahey T et al. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis. PLoS ONE 2016;11(12):e0168521
Lahey T et al
2016/01/01
Sample Type: Whole Cells PubMed
59 Xu C et al. Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection. BMC Infect. Dis. 2018 Apr;18(1):195
Xu C et al
2018/01/01
Species: Mouse PubMed
60 Taghinezhad-S S et al. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein. Microb. Pathog. 2019 Jan;126:149-156
Taghinezhad-S S et al
2019/01/01
PubMed
61 Sun W et al. A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses. Cell. Mol. Immunol. 2018 Aug;15(8):768-781
Sun W et al
2018/01/01
PubMed
62 Mohseni AH et al. Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis. BMC Biotechnol. 2019 01;19(1):8
Mohseni AH et al
2019/01/01
PubMed
63 Gage E et al. Memory CD4<sup>+</sup> T cells enhance B-cell responses to drifting influenza immunization. Eur. J. Immunol. 2019 Feb;49(2):266-276
Gage E et al
2019/01/01
PubMed
64 Deng J et al. Broad and Effective Protection against Staphylococcus aureus Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens. mSphere 2019 09;4(5)
Deng J et al
2019/01/01
PubMed
65 Aligholipour Farzani T et al. Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models. Vaccines (Basel) 2019 Sep;7(3)
Aligholipour Farzani T et al
2019/01/01
PubMed
66 Hwang HS et al. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression. Cells 2020 11;9(11)
Hwang HS et al
2020/01/01
Species: Mouse PubMed
67 Dub辿 JY et al. Synthetic mycobacterial molecular patterns partially complete Freund&quot;s adjuvant. Sci Rep 2020 04;10(1):5874
Dub辿 JY et al
2020/01/01
Species: Mouse PubMed
  • No.: 1
  • 文献情報:
    Chen BJ et al. Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. Blood 2002 May;99(9):3083-8
    Chen BJ et al
    2002/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Baron JL et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002 Apr;16(4):583-94
    Baron JL et al
    2002/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Dredge K et al. Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity. J. Immunol. 2002 May;168(10):4914-9
    Dredge K et al
    2002/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Maecker B et al. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood 2003 Nov;102(9):3287-94
    Maecker B et al
    2003/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Wan T et al. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 2004 Mar;103(5):1747-54
    Wan T et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Huang YH et al. Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens. J. Virol. 2003 Dec;77(24):12980-5
    Huang YH et al
    2003/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Wang D et al. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs. Int. J. Oncol. 2004 Apr;24(4):901-8
    Wang D et al
    2004/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Li AF et al. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine 2004 Apr;22(13-14):1751-63
    Li AF et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Kwak H et al. Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion. Virology 2004 May;322(2):337-48
    Kwak H et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Luby TM et al. Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1. Clin. Immunol. 2004 Jul;112(1):45-
    Luby TM et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Sakai Y et al. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice. Cancer Res. 2004 Nov;64(21):8022-8
    Sakai Y et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Lou Y et al. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res. 2005 Sep;65(17):7926-33
    Lou Y et al
    2005/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Aulwurm S et al. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo. Int. J. Cancer 2006 Apr;118(7):1728-35
    Aulwurm S et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Berm炭dez-Humar叩n LG et al. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol. 2005 Dec;175(11):7
    Berm炭dez-Humar叩n LG et al
    2005/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Savino C et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J. Neuroimmunol. 2006 Mar;172(1-2):27-37
    Savino C et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Malowany JI et al. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol. Ther. 2006 Apr;13(4):766-75
    Malowany JI et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Ma XT et al. Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses. Cancer Res. 2006 Jan;66(2):1169-76
    Ma XT et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Young KR et al. Elicitation of immunity to HIV type 1 Gag is determined by Gag structure. AIDS Res. Hum. Retroviruses 2006 Jan;22(1):99-108
    Young KR et al
    2006/01/01
  • 備考:
    Application: ELISpot Development, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Kumar S et al. Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India. Vaccine 2006 Mar;24(14):2585-93
    Kumar S et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Ohmura-Hoshino M et al. Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 2006 Jul;177(1):341-54
    Ohmura-Hoshino M et al
    2006/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Blazevic V et al. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. AIDS Res. Hum. Retroviruses 2006 Jul;22(7):667-77
    Blazevic V et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Zhao X et al. Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag. J. Virol. 2006 Sep;80(18):8880-90
    Zhao X et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Viner KM et al. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals. Virology 2007 May;361(2):356-63
    Viner KM et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Kurooka M et al. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res. 2007 Jan;67(1):227-36
    Kurooka M et al
    2007/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Lou Y et al. Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1. Vaccine 2007 Mar;25(12):2331-9
    Lou Y et al
    2007/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Malm M et al. GTU-MultiHIV DNA vaccine results in protection in a novel P815 tumor challenge model. Vaccine 2007 Apr;25(17):3293-301
    Malm M et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Song S et al. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice. Vaccine 2007 Jun;25(25):4853-60
    Song S et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Xu B et al. Synergistic antileukemia effect of combinational gene therapy using murine beta-defensin 2 and IL-18 in L1210 murine leukemia model. Gene Ther. 2007 Aug;14(15):1181-7
    Xu B et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Manning EA et al. A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism. Clin. Cancer Res. 2007 Jul;13(13):3951-9
    Manning EA et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Gill N et al. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15. Eur. J. Immunol. 2007 Sep;37(9):2529-38
    Gill N et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Cortes-Perez NG et al. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 2007 Sep;25(36):6581-8
    Cortes-Perez NG et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Yamaguchi S et al. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines. Cancer 2007 Oct;110(7):1469-77
    Yamaguchi S et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Barcia C et al. One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications. Mol. Ther. 2007 Dec;15(12):2154-63
    Barcia C et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Koncz A et al. Nitric oxide mediates T cell cytokine production and signal transduction in histidine decarboxylase knockout mice. J. Immunol. 2007 Nov;179(10):6613-9
    Koncz A et al
    2007/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Yang J et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation 2008 Feb;117(5):660-9
    Yang J et al
    2008/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Lopez R et al. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J. Immunol. 2008 Oct;181(7):4908-17
    Lopez R et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Whole Cells
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Dagenais TR et al. T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions. Infect. Immun. 2009 Jan;77(1):141-51
    Dagenais TR et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Divangahi M et al. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 2008 Nov;181(10):7157-65
    Divangahi M et al
    2008/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Zhu Q et al. Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection. Mucosal Immunol 2008 Jan;1(1):78-88
    Zhu Q et al
    2008/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Robinson M et al. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J. Virol. 2009 Apr;83(8):3450-62
    Robinson M et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    McBurney SP et al. Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine 2009 Jul;27(32):4337-49
    McBurney SP et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Kopecky-Bromberg SA et al. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 2009 Jun;27(28):3766-74
    Kopecky-Bromberg SA et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    M旦lder T et al. Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV--study in domestic pigs. Vaccine 2009 Dec;28(2):293-8
    M旦lder T et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    De Koker S et al. Biodegradable polyelectrolyte microcapsules: antigen delivery tools with Th17 skewing activity after pulmonary delivery. J. Immunol. 2010 Jan;184(1):203-11
    De Koker S et al
    2010/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Masalova OV et al. The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization. Vaccine 2010 Feb;28(8):1987-96
    Masalova OV et al
    2010/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Ponte JF et al. Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody. Immunology 2010 Jun;130(2):231-42
    Ponte JF et al
    2010/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Kundu S et al. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J. Immunol. 2010 Jun;184(11):6529-36
    Kundu S et al
    2010/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Wu CY et al. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS ONE 2012;7(8):e42363
    Wu CY et al
    2012/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Savino MT et al. The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. J. Leukoc. Biol. 2013 Apr;93(4):549-59
    Savino MT et al
    2013/01/01
  • 備考:
    Sample Type: cell supernates
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Walsh MP et al. Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. PLoS ONE 2013;8(3):e58860
    Walsh MP et al
    2013/01/01
  • 備考:
    Sample Type: tissue homogenate
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Gupta S et al. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag. J. Virol. 2014 Feb;88(3):1492-501
    Gupta S et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Lv L et al. Production and immunogenicity of chimeric virus-like particles containing the spike glycoprotein of infectious bronchitis virus. J. Vet. Sci. 2014;15(2):209-16
    Lv L et al
    2014/01/01
  • 備考:
    Sample Type: cell supernates
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Kanagavelu S et al. HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity. PLoS ONE 2014;9(2):e90100
    Kanagavelu S et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Kumari S et al. Epidermal RelA specifically restricts contact allergen-induced inflammation and apoptosis in skin. J. Invest. Dermatol. 2014 Oct;134(10):2541-50
    Kumari S et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Reynolds C et al. Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile. BMC Biol. 2014;12:32
    Reynolds C et al
    2014/01/01
  • 備考:
    Sample Type: Cell culture media
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    King TH et al. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS ONE 2014;9(7):e101904
    King TH et al
    2014/01/01
  • 備考:
    Sample Type: cell suspensions
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Gil-Farina I et al. Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis. J. Immunol. 2016 Sep;197(6):2145-56
    Gil-Farina I et al
    2016/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Lahey T et al. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis. PLoS ONE 2016;11(12):e0168521
    Lahey T et al
    2016/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Xu C et al. Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection. BMC Infect. Dis. 2018 Apr;18(1):195
    Xu C et al
    2018/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Taghinezhad-S S et al. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein. Microb. Pathog. 2019 Jan;126:149-156
    Taghinezhad-S S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Sun W et al. A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses. Cell. Mol. Immunol. 2018 Aug;15(8):768-781
    Sun W et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Mohseni AH et al. Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis. BMC Biotechnol. 2019 01;19(1):8
    Mohseni AH et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Gage E et al. Memory CD4<sup>+</sup> T cells enhance B-cell responses to drifting influenza immunization. Eur. J. Immunol. 2019 Feb;49(2):266-276
    Gage E et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Deng J et al. Broad and Effective Protection against Staphylococcus aureus Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens. mSphere 2019 09;4(5)
    Deng J et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Aligholipour Farzani T et al. Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models. Vaccines (Basel) 2019 Sep;7(3)
    Aligholipour Farzani T et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Hwang HS et al. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression. Cells 2020 11;9(11)
    Hwang HS et al
    2020/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Dub辿 JY et al. Synthetic mycobacterial molecular patterns partially complete Freund&quot;s adjuvant. Sci Rep 2020 04;10(1):5874
    Dub辿 JY et al
    2020/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed